Fingerprint
Dive into the research topics of 'Pharmacokinetics and safety of glecaprevir and pibrentasvir in HCV-negative subjects with hepatic impairment'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pharmacokinetics and safety of glecaprevir and pibrentasvir in HCV-negative subjects with hepatic impairment
Matthew P. Kosloski, Haoyu Wang, David Pugatch, Federico J. Mensa, Edward Gane, Eric Lawitz, Thomas C. Marbury, Richard A. Preston, Jens Kort, Wei Liu
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations